In view of the potent in vitro effects of fatostatin and docetaxel on the growth of p53 null or mutant PCa cells (parental PC-3 and DU145 cells), we next evaluated the therapeutic potential of fatostatin and/or docetaxel in immunodeficient mice. The gene discussed is TP53; the disease is posterior cortical atrophy.